Effect of Covid-19 Epidemic on Primary PCI in Patients With STEMI
1 other identifier
observational
200
1 country
1
Brief Summary
The epidemic of covid-19 has spread all over the world and has a great impact on people's health and life. It is necessary to study the treatment of STEMI patients in the real world under the influence of the epidemic,which provide effective suggestions and strategies for emergency and severe treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 24, 2019
CompletedFirst Submitted
Initial submission to the registry
June 9, 2020
CompletedFirst Posted
Study publicly available on registry
June 11, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 24, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 24, 2021
CompletedJune 11, 2020
June 1, 2020
2.5 years
June 9, 2020
June 10, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
MACE (major adverse cardiovascular events)
cardiovascular death, re-infarction, malignant arrhythmia,heart failure, revascularization, and stroke
1 year
all-cause death
death caused by all reason
1 year
Study Arms (2)
before COVID-19
Patients with myocardial infarction from January 24, 2019 to June 24, 2019
after COVID-19
Patients with myocardial infarction from January 24, 2020 to June 24, 2020
Eligibility Criteria
patients with definite diagnosis of acute ST segment elevation myocardial infarction and emergency PCI intervention
You may not qualify if:
- Febrile patients, patients with severe infection,
- ST segment elevation myocardial infarction during hospitalization,
- Patients who could not cooperate with each other.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Friendship Hospital, Capital Medical University
Beijing, China
Related Publications (1)
Gong X, Zhou L, Dong T, Ding X, Zhao H, Chen H, Li H. Impact of COVID-19 pandemic on STEMI undergoing primary PCI treatment in Beijing, China. Am J Emerg Med. 2022 Mar;53:68-72. doi: 10.1016/j.ajem.2021.11.034. Epub 2021 Nov 24.
PMID: 34999563DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Hongwei Li
Beijing Friendship Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
June 9, 2020
First Posted
June 11, 2020
Study Start
January 24, 2019
Primary Completion
July 24, 2021
Study Completion
July 24, 2021
Last Updated
June 11, 2020
Record last verified: 2020-06